Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CSL

CSL
1916 FOUNDED
PUBLIC STATUS
1K-5K EMPLOYEES
CSL STOCK SYMBOL
5 INVESTMENTS
$206.98 SHARE PRICE (As of Friday Closing)
Description

CSL is the one of largest global biotech companies. Products are focused on two key areas - protein science therapies such as plasma-derived immunoglobulins for the treatment of immune deficiencies and neurological conditions, in its CSL Behring division, and influenza vaccines, in its Seqirus division. CSL has a strong research and development track record. The portfolio and pipeline include non-plasma products as the company broadens its biotech scope. Originally formed in Australia as a commonwealth-owned entity, CSL now earns half its revenue in North America and a quarter in Europe.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
ASX
Primary Office
  • 45 Poplar Road
  • Parkville, Victoria 3052
  • Australia

+61 (03) 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CSL’s full profile, request a free trial.

CSL Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$131.08 - $208.91 $93.8B $207.82 $3.03 768K 453M

CSL Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2019
30-Jun-2019
FY 2018
30-Jun-2018
FY 2017
30-Jun-2017
Enterprise Value 71,006,569 71,006,569 66,805,461 50,477,854
Revenue 6,084,715 6,084,715 5,877,628 4,985,569
EBITDA 2,058,817 2,058,817 2,073,618 1,454,645
Net Income 1,371,901 1,371,901 1,339,215 1,007,845
Total Assets 8,624,254 8,624,254 7,914,861 7,010,343
Total Debt 3,265,541 3,265,541 3,222,141 3,054,744
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CSL Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore CSL‘s full profile, request access.

Request full access to PitchBook

CSL Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
China Biologic Products Holdings Corporation Beijing, China 0000 00000 000000000000 00000
0000 0000000000000 Corporate Backed or Acquired Petach Tikva, Israel 00000 00000 00000000000 00000
000000 00000 Corporation Mumbai, India 0000
000000 000000000 Corporation Oxford, United Kingdom 000 00000 000000000 00 00000
00000000000 Formerly PE-Backed Cambridge, United Kingdom 00000 000 00000000 000
To view this company’s complete list of competitors, request access »

CSL Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 11-Sep-2017 000000000000000000 00000 Biotechnology 0000 000000000
00000 00000 0000 0 03-Aug-2017 000000000000000000 00000 Drug Discovery 0000 000000000
0000000 03-Aug-2015 000000000000000000 00000 Other Pharmaceuticals and Biotechnology 0000 000000000
0000000000000 0000 09-Apr-2006 00000 00000 00 000 Consulting Services (B2B)
Aventis Behring 31-Mar-2004 Merger/Acquisition Medical Supplies 00000 0000000
To view this company’s complete investment and acquisition history, request access »

CSL Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000000000 0000 09-Apr-2006 00000 00000 00 000 Completed
  • 3 buyers
To view this company’s complete exits history, request access »

CSL Subsidiaries (3)

Company Name Industry Location Founded
CSL Plasma Other Software 2019
0000000 Other Pharmaceuticals and Biotechnology Holly Springs, NC 0000
000000000 Biotechnology Tucson, AZ 0000
To view this company’s complete subsidiary history, request access »

CSL Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore CSL‘s full profile, request access.

Request full access to PitchBook

CSL Executive Team (1)

Name Title Board
Seat
Contact
Info
Paul Perreault Chief Executive Officer & Managing Director & Board Member

CSL Board Members (9)

Name Representing Role Since Contact
Info
00000 0000000 CSL Board Member 000 0000
00000 00000 CSL Board Member 000 0000
000000000 0'000000 CSL Board Member 000 0000
00000 0000000 Self Board Member 000 0000
0000 00000 CSL Chairman 000 0000
You’re viewing 5 of 9 board members. Get the full list »